Biochemistry, Genetics and Molecular Biology
Insulin-Like Growth Factor
84%
Insulin Receptor
55%
Antibody
53%
Cancer Cell
48%
Insulin-Like Growth Factor 1 Receptor
44%
Maltose-Binding Protein
42%
Proteases
39%
Growth
37%
Protein
32%
Peptide
30%
Solubility
28%
Mouse
23%
Clinical Trial
23%
Escherichia coli
21%
down Regulation
16%
Mouse Model
16%
Insulin
16%
Epidermal Growth Factor
14%
Development
14%
Growth Factor
14%
pH
14%
Fourier Transform
14%
Thioredoxin
14%
Fibroblast Growth Factor
14%
Osteoclast Activity
14%
Magnetic Resonance Imaging
14%
Interleukin-4 Receptor
14%
Immunogenicity
14%
Perlecan
14%
Comprehension
14%
Coil
10%
Pepsin
10%
Time
9%
Cathepsin D
8%
Surface Property
8%
Phosphorylation
8%
Multigene Family
7%
Osteoclastogenesis
7%
Lysosome
7%
Renin
7%
Precursor
7%
Chimera
7%
C-Terminus
7%
Phenotype
6%
Fusion Protein
6%
Soluble Protein
6%
Mutagenesis
5%
B Cell
5%
Osteoclast
5%
Medicine and Dentistry
Breast Cancer
100%
Somatomedin C Receptor
61%
Cancer Cell
60%
Cells
52%
Metastatic Carcinoma
44%
Somatomedin C
42%
Insulin Receptor
35%
Combination Therapy
33%
Somatomedin
32%
down Regulation
32%
Receptor
31%
Cancer Therapy
30%
Antibody
21%
Receptor down Regulation
17%
Cell Proliferation
16%
Protein Tyrosine Kinase
15%
Lung
15%
Single Chain Fragment Variable Antibody
15%
Signal Transduction Inhibitor
14%
Magnetic Resonance Imaging
14%
Osteoclast Activity
14%
Lesion
14%
Fibroblast Growth Factor
14%
Chimeric Antigen Receptor T-Cell
14%
Sarcoma
14%
Tamoxifen
14%
Transactivation
14%
MCF-7
13%
Growth
12%
Patient
12%
Tumor Cell
10%
Cell Type
10%
In Vitro
10%
Insulin
8%
Xenograft
8%
Osteoclastogenesis
7%
Signal Transduction
7%
Cancer Growth
6%
Therapeutic Procedure
6%
Short Hairpin RNA
5%
Cancer Treatment
5%
Phosphorylation
5%
Survival
5%
Osteoclast
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
97%
Somatomedin C Receptor
67%
Somatomedin
60%
Antibody
58%
Malignant Neoplasm
55%
Somatomedin Receptor
42%
Somatomedin C
37%
Insulin Receptor
35%
Metastasis
33%
Clinical Trial
22%
Survival
21%
Single Chain Fragment Variable Antibody
18%
Drug
17%
Tumor Growth
17%
Chemotherapy
16%
Protein Tyrosine Kinase
15%
Tamoxifen
14%
Immunogenicity
14%
Mouse Model
14%
Breast Carcinoma
14%
Gamma Urogastrone
14%
Quantum Dot
14%
Antibody Conjugate
14%
Primary Tumor
14%
Toxin
14%
Calcium Ion
14%
Doxorubicin
14%
Interleukin 4 Receptor
14%
Neoplasm
13%
Insulin
13%
Receptor
10%
Mutagenesis
8%
Paclitaxel
7%
Rheumatoid Arthritis
7%
Carboplatin
7%
Immunoglobulin G2
7%
Preclinical Study
7%
Biological Marker
6%
Cytokine
5%
Cell Proliferation
5%
Ligand
5%